美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Prospect Capital Corp

25.06

+0.0000

成交量：- -

成交额：31.97万

市值：92.18亿

市盈率：68.17

高：25.06

开：25.06

低：25.06

收：25.06

数据加载中...

总览公司新闻公告

金十数据整理：每日美股市场要闻速递（11月20日周三）

葛兰素史克(GSK.US)IBAT抑制剂治疗PBC相关胆汁淤积性瘙痒III期研究成功

Tharimmune, Inc.盘中异动早盘快速上涨5.07%报2.28美元

Tharimmune, Inc.盘中异动早盘股价大跌5.12%报2.04美元

Zevia PBC 预计每股亏损8美分 - 财报前瞻

专访吉利德副总裁、中国总经理金方千：拥抱进博溢出效应，促进医疗创新合作

21世纪经济报道

Tharimmune, Inc.盘中异动股价大跌5.61%报2.69美元

Tharimmune, Inc.盘中异动早盘急速下挫5.68%

FTX前工程总监Nishad Singh被判决免于入狱

Tharimmune, Inc.盘中异动早盘快速拉升181.28%

大模型太“烧钱”！OpenAI预计2026年将亏损140亿美元，2029年才能盈利，财务重压之下拟转向全新公司结构

每日经济新闻

OpenAI计划采用公益企业结构以抵御敌意收购

英媒：OpenAI计划采用公益企业结构以抵御敌意收购

Tharimmune, Inc.盘中异动股价大涨5.98%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PBC/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"退市","change":0,"latestTime":"12-29 16:00:00 EST","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743753600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","floatShares":0,"roa":"4.83%","roe":"4.16%","lyrEps":0.394789,"shares":367817926,"dividePrice":0.72,"high":25.06,"amplitude":0,"preClose":25.06,"low":25.06,"week52Low":25,"pbRate":"2.90","week52High":26.49,"institutionHeld":0,"latestPrice":25.06,"eps":0.367626,"divideRate":0.028731,"volume":0,"delay":0,"ttmEps":0.367626,"open":25.06},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBC\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2484169121","title":"金十数据整理：每日美股市场要闻速递（11月20日 周三）","url":"https://stock-news.laohu8.com/highlight/detail?id=2484169121","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484169121?lang=zh_cn&edition=fundamental","pubTime":"2024-11-20 21:29","pubTimestamp":1732109340,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IBAT","IE0004086264.USD","LU0225283273.USD","IE00B19Z8X17.USD","TSLL","NVDS.UK","IE0034235303.USD","NVD","LU2092627202.USD","NVD3.UK","INTC","PBC","3NVD.UK","NVDU","0HAF.UK","GSK.UK","LU0157215616.USD","2NVD.UK","NOK","GSK","LU0276348264.USD","ATHM","09866","NVDA","NVDL","NIO.SI","NVDS","NVDX","NIO","02518","BK4114","IE0009G5SDU7.USD","SMSN.UK","III","YMM","TGT","NVD2.UK","LU0345770993.USD","LU0511384066.AUD","NVDY","SNVD.UK","LU0708995583.HKD","AAPL","SY","LU1935042991.SGD","TSLA","EVS.SI","NVDD","LU0289961442.SGD","LU1098665638.USD"],"gpt_icon":0},{"id":"2484211569","title":"葛兰素史克(GSK.US)IBAT抑制剂治疗PBC相关胆汁淤积性瘙痒III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2484211569","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484211569?lang=zh_cn&edition=fundamental","pubTime":"2024-11-20 21:05","pubTimestamp":1732107905,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月19日，葛兰素史克宣布III期GLISTEN研究取得了积极结果。该研究旨在评估回肠胆汁酸转运蛋白抑制剂Linerixibat治疗原发性胆汁性胆管炎相关的胆汁淤积性瘙痒成人患者的疗效和安全性。PBC是一种罕见的胆道疾病，主要影响女性，如果不进行治疗，可能导致肝脏损伤甚至肝衰竭。Linerixibat是一种口服的IBAT抑制剂，通过抑制胆汁酸的再摄取，旨在从根本上解决胆汁淤积性瘙痒。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1829250122.USD","BK4532","GSK.UK","III","BK4588","BK4007","GSK","BK4134","IBAT","PBC","BK4585"],"gpt_icon":0},{"id":"2484667987","title":"Tharimmune, Inc.盘中异动 早盘快速上涨5.07%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484667987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484667987?lang=zh_cn&edition=fundamental","pubTime":"2024-11-18 22:32","pubTimestamp":1731940333,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Tharimmune, Inc.股票出现异动，股价快速拉升5.07%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为516.39%、196.71%、186.34%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Biomx Inc.，振幅分别为46.50%、31.28%、19.34%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822321395be485f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822321395be485f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","THAR","BK4139"],"gpt_icon":0},{"id":"2483488432","title":"Tharimmune, Inc.盘中异动 早盘股价大跌5.12%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483488432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483488432?lang=zh_cn&edition=fundamental","pubTime":"2024-11-13 22:33","pubTimestamp":1731508398,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时33分，Tharimmune, Inc.股票出现波动，股价急速下跌5.12%。截至发稿，该股报2.04美元/股，成交量97.7532万股，换手率85.09%，振幅1.40%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223318971a647d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223318971a647d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PBC","THAR"],"gpt_icon":0},{"id":"2480558042","title":"Zevia PBC   预计每股亏损8美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480558042","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480558042?lang=zh_cn&edition=fundamental","pubTime":"2024-11-04 23:44","pubTimestamp":1730735094,"startTime":"0","endTime":"0","summary":"   * Zevia PBC    将于11月6日公布截至2024年9月30日的财报，预计季度收入将出现下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州恩西诺的公司的营收将从去年同期的4309万美元下降9.4%，至3903.6万美元。* LSEG 分析师对 Zevia PBC 的平均预期是每股亏损 8 美分。* 华尔街对 Zevia PBC 的 12 个月目标价中位数为 2.00 美元，高于上一次收盘价 1.16 美元。11月4日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVIA","PBC"],"gpt_icon":0},{"id":"2480812472","title":"专访吉利德副总裁、中国总经理金方千：拥抱进博溢出效应，促进医疗创新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2480812472","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480812472?lang=zh_cn&edition=fundamental","pubTime":"2024-11-02 14:22","pubTimestamp":1730528578,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛上海报道随着中国医疗改革的持续深入，创新药物的发展在中国迎来了黄金时期。中国的医药健康行业正翻开历史新篇章，从最初的医药创新追随者逐步转变为并行者，甚至在某些领域成为领跑者。在过去的数十年中，跨国制药企业通过共同建设，助力中国成为全球第二大医药医疗消费市场。它们为中国医药行业注入了资金、技术，并引入了新的市场结构与理念。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411023227121810.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411023227121810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBC"],"gpt_icon":0},{"id":"2480889493","title":"Tharimmune, Inc.盘中异动 股价大跌5.61%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480889493?lang=zh_cn&edition=fundamental","pubTime":"2024-11-01 21:30","pubTimestamp":1730467859,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时30分，Tharimmune, Inc.股票出现波动，股价快速下跌5.61%。截至发稿，该股报2.69美元/股，成交量2.1506万股，换手率1.87%，振幅0.00%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213059971a3d59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213059971a3d59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"gpt_icon":0},{"id":"2479038128","title":"Tharimmune, Inc.盘中异动 早盘急速下挫5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479038128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479038128?lang=zh_cn&edition=fundamental","pubTime":"2024-10-31 21:31","pubTimestamp":1730381463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时31分，Tharimmune, Inc.股票出现异动，股价急速跳水5.68%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为1.28%。其相关个股中，Aerovate Therapeutics, Inc.、Evogene Ltd.、Day One Biopharmaceuticals, Inc.涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为188.48%、184.24%、144.61%，振幅较大的相关个股有Equillium, Inc.、Enanta Pharmaceuticals, Inc.、Aerovate Therapeutics, Inc.，振幅分别为12.32%、6.96%、5.48%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213103ab8b7f97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213103ab8b7f97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"gpt_icon":0},{"id":"2479179743","title":"FTX前工程总监Nishad Singh被判决免于入狱","url":"https://stock-news.laohu8.com/highlight/detail?id=2479179743","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479179743?lang=zh_cn&edition=fundamental","pubTime":"2024-10-31 08:57","pubTimestamp":1730336220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/268561","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["PBC"],"gpt_icon":0},{"id":"2479788935","title":"Tharimmune, Inc.盘中异动 早盘快速拉升181.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479788935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479788935?lang=zh_cn&edition=fundamental","pubTime":"2024-10-30 21:30","pubTimestamp":1730295005,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时30分，Tharimmune, Inc.股票出现异动，股价快速拉升181.28%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Renovorx, Inc.、Newamsterdam Pharma Company N.V.、Zymeworks Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1587.33%、91.57%、13.62%，振幅较大的相关个股有Tempest Therapeutics, Inc.、Zymeworks Inc.、Zyversa Therapeutics, Inc.，振幅分别为0.70%、0.00%、0.00%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213005a1faccd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213005a1faccd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","THAR","BK4139"],"gpt_icon":0},{"id":"2474721382","title":"大模型太“烧钱”！OpenAI预计2026年将亏损140亿美元，2029年才能盈利，财务重压之下拟转向全新公司结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2474721382","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474721382?lang=zh_cn&edition=fundamental","pubTime":"2024-10-10 19:27","pubTimestamp":1728559643,"startTime":"0","endTime":"0","summary":"每经记者：郑雨航 每经实习记者：岳楚鹏    每经编辑：兰素英图片来源：视觉中国-VCG31N2008743681AI领域的领军者OpenAI正在面临着前所未有的挑战。当地时间10月9日，据外媒报道，尽管在最新一轮66亿美元的融资中，OpenAI的估值达到1570亿美元，但公司仍需应对高达数十亿美元的年度亏损，以及未来几年巨额的运营成本。...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/ONAHr6WHJEAi2-BGNZlnnPCMlxV2_GAzQzbt274QRws6cAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/ONAHr6WHJEAi2-BGNZlnnPCMlxV2_GAzQzbt274QRws6cAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241010A08LAE00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241010A08LAE00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["PBC"],"gpt_icon":0},{"id":"2474271383","title":"OpenAI计划采用公益企业结构以抵御敌意收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2474271383","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474271383?lang=zh_cn&edition=fundamental","pubTime":"2024-10-10 01:01","pubTimestamp":1728493260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/266210","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK4516","BK4535","BK4097","IE0034235188.USD","IE00BJTD4N35.SGD","BK4587","BK4567","IE00B19Z8X17.USD","IE00BJLML261.HKD","IE00B4YYXB79.USD","IE00B7KXQ091.USD","BK4576","IE000ITXATA3.USD","IE00BDRTCR15.USD","IE00B1XK9C88.USD","IE0004091025.USD","GB00B4QBRK32.GBP","IE0034235303.USD","IE00B3SWFQ91.USD","BK4585","BK4528","IE00BK4W5L77.USD","IE00BK4W5M84.HKD","IE00BKVL7J92.USD","PBC","MSFT","BK4579","IE0009G5SDU7.USD","BK4566","IE00B5TLWC47.USD","IE00BKPKM429.USD","IE0009356076.USD","161631","IE00B775H168.HKD","BK4533","IE00BJTD4V19.USD","IE00BJJMRY28.SGD","BK4527","GB00BDT5M118.USD","IE000KEQY171.SGD","IE00BLSP4239.USD","BK4550","BK4548","BK4577","IE00B1BXHZ80.USD","IE00BFXG0V08.USD","BK4554","BK4592","IE00B775SV38.USD"],"gpt_icon":0},{"id":"2474763632","title":"英媒：OpenAI计划采用公益企业结构以抵御敌意收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2474763632","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474763632?lang=zh_cn&edition=fundamental","pubTime":"2024-10-10 00:34","pubTimestamp":1728491681,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4587","BK4592","BK4097","BK4579","IE00BLSP4239.USD","IE0004086264.USD","BK4503","IE0004445239.USD","IE00B1XK9C88.USD","IE00BJTD4N35.SGD","IE0009G5SDU7.USD","IE0009356076.USD","IE00BKPKM429.USD","IE0003U64NQ7.SGD","BK4528","BK4525","GB00B4QBRK32.GBP","BK4576","BK4585","GB00B4LPDJ14.GBP","IE0005OL40V9.USD","IE00BBT3K403.USD","IE0034235303.USD","IE00BK4W5L77.USD","BK4566","BK4567","IE000W1ABFV2.USD","IE00BFSS7M15.SGD","IE00B775H168.HKD","IE00BJLML261.HKD","IE00B3SWFQ91.USD","IE00B7KXQ091.USD","BK4577","IE00B3S45H60.SGD","IE00B4YYXB79.USD","IE00BDRTCR15.USD","MSFT","IE00B19Z9505.USD","BK4516","IE000KEQY171.SGD","PBC","IE00BKDWB100.SGD","IE00B1BXHZ80.USD","161631","IE00B5TLWC47.USD","IE00BK4W5M84.HKD","IE00BFSS8Q28.SGD","BK4588","BK4550"],"gpt_icon":0},{"id":"2474114408","title":"Tharimmune, Inc.盘中异动 股价大涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474114408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474114408?lang=zh_cn&edition=fundamental","pubTime":"2024-10-09 00:16","pubTimestamp":1728404160,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时16分，Tharimmune, Inc.股票出现波动，股价大幅上涨5.98%。截至发稿，该股报2.03美元/股，成交量1.8837万股，换手率1.64%，振幅7.31%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090016009719f033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090016009719f033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-30","symbol":"PBC","reason":null,"defaultRemindTime":1640874600000,"announcedDate":"2021-12-01","type":"delisting","dateTimestamp":1640840400000},{"market":"US","date":"2021-11-30","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1638282600000,"name":"Prospect Capital Corp","recordDate":"2021-12-15","payableDate":"2021-12-01","currency":"USD","type":"dividend","dateTimestamp":1638248400000},{"market":"US","date":"2021-08-31","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1630416600000,"name":"Prospect Capital Corp","recordDate":"2021-09-15","payableDate":"2021-09-01","currency":"USD","type":"dividend","dateTimestamp":1630382400000},{"market":"US","date":"2021-05-28","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1622208600000,"name":"Prospect Capital Corp","recordDate":"2021-06-15","payableDate":"2021-06-01","currency":"USD","type":"dividend","dateTimestamp":1622174400000},{"market":"US","date":"2021-02-26","symbol":"PBC","amount":0.4296875,"name":"Prospect Capital Corp","recordDate":"2021-03-15","payableDate":"2021-03-01","currency":"USD","type":"dividend","dateTimestamp":1614315600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBC\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-15","value":0.4774306,"currency":"USD"},{"executeDate":"2019-08-29","recordDate":"2019-08-30","paymentDate":"2019-09-15","value":0.4296875,"currency":"USD"},{"executeDate":"2019-11-27","recordDate":"2019-11-29","paymentDate":"2019-12-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":"2020-03-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-05-29","recordDate":"2020-06-01","paymentDate":"2020-06-15","value":0.4296875,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBC\",market:\"US\",delay:false,,,undefined,":{}}}